Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Diabetes Therapeutics Market Research Reports

Titlepublishedprice

Diabetic Foot Ulcers - Pipeline Review, H2 2016

By Global Markets Direct
"...... 1 Diabetes and Type 2 Diabetes. Symptoms include sores, ulcers, or blisters on the foot or lower leg, pain, walking with difficulty, discoloration in feet: black, blue, or red, cold feet and fever, skin redness or swelling, or other signs of infecti......"
23-Nov-2016$2000

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

By Global Markets Direct
"...... ase in which a pancreas stops producing insulin, a hormone that enables people to get energy from food. It occurs when the body's immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. Risk factors of type ......"
16-Nov-2016$2000

Type 2 Diabetes - Pipeline Review, H2 2016

By Global Markets Direct
"...... h levels of glucose are a characteristic feature. The body might become resistant to insulin or may not produce enough amounts. Due to abnormal insulin functioning, glucose is concentrated in the blood leading to elevated levels and hence causing typ......"
09-Nov-2016$2500

Diabetic Foot Infection (DFI)-Pipeline Insights, 2016

By Delve Insight
"...... g Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent a......"
01-Nov-2016$1250

Diabetic Foot Ulcers-Pipeline Insights, 2016

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Nov-2016$1250

Diabetic Gastroparesis-Pipeline Insights, 2016

By Delve Insight
"...... re-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA......"
01-Nov-2016$1250

Diabetic Macular Edema-Pipeline Insights, 2016

By Delve Insight
"...... re-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA......"
01-Nov-2016$1250

Diabetes Insipidus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... Report is to understand the market and pipeline status of the drugs around the Diabetes Insipidus to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The Delve......"
01-Nov-2016$2000

Diabetic Nephropathy-Pipeline Insights, 2016

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Nov-2016$1250

Diabetic Foot Infection (DFI)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... c Foot Infection (DFI) Report is to understand the market and pipeline status of the drugs around the Diabetic Foot Infection (DFI) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designi......"
01-Nov-2016$2000

Avail upto 50% Discount on below Publisher Reports.